1. Home
  2. FHN vs VTRS Comparison

FHN vs VTRS Comparison

Compare FHN & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHN
  • VTRS
  • Stock Information
  • Founded
  • FHN 1864
  • VTRS 1961
  • Country
  • FHN United States
  • VTRS United States
  • Employees
  • FHN N/A
  • VTRS N/A
  • Industry
  • FHN Major Banks
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • FHN Finance
  • VTRS Health Care
  • Exchange
  • FHN Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • FHN 9.9B
  • VTRS 11.0B
  • IPO Year
  • FHN N/A
  • VTRS N/A
  • Fundamental
  • Price
  • FHN $19.21
  • VTRS $8.68
  • Analyst Decision
  • FHN Buy
  • VTRS Hold
  • Analyst Count
  • FHN 16
  • VTRS 4
  • Target Price
  • FHN $21.91
  • VTRS $10.50
  • AVG Volume (30 Days)
  • FHN 7.3M
  • VTRS 17.9M
  • Earning Date
  • FHN 04-16-2025
  • VTRS 05-08-2025
  • Dividend Yield
  • FHN 3.12%
  • VTRS 5.53%
  • EPS Growth
  • FHN N/A
  • VTRS N/A
  • EPS
  • FHN 1.36
  • VTRS N/A
  • Revenue
  • FHN $3,040,000,000.00
  • VTRS $14,739,300,000.00
  • Revenue This Year
  • FHN $12.40
  • VTRS N/A
  • Revenue Next Year
  • FHN $4.98
  • VTRS $0.99
  • P/E Ratio
  • FHN $14.14
  • VTRS N/A
  • Revenue Growth
  • FHN 1.95
  • VTRS N/A
  • 52 Week Low
  • FHN $13.72
  • VTRS $8.62
  • 52 Week High
  • FHN $22.44
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • FHN 43.43
  • VTRS 29.72
  • Support Level
  • FHN $18.86
  • VTRS $9.01
  • Resistance Level
  • FHN $20.06
  • VTRS $9.35
  • Average True Range (ATR)
  • FHN 0.49
  • VTRS 0.27
  • MACD
  • FHN 0.12
  • VTRS 0.00
  • Stochastic Oscillator
  • FHN 64.58
  • VTRS 5.56

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: